Change in Urinary Myoinositol/Citrate Ratio Associates with Progressive Loss of Renal Function in ADPKD Patients

INTRODUCTION: In autosomal dominant polycystic kidney disease (ADPKD) patients, predicting renal disease progression is important to make a prognosis and to support the clinical decision whether to initiate renoprotective therapy. Conventional markers all have their limitations. Metabolic profiling...

Descripción completa

Detalles Bibliográficos
Autores principales: Dekker, Shosha E.I., Verhoeven, Aswin, Frey, Daria, Soonawala, Darius, Peters, Dorien J.M., Mayboroda, Oleg A., de Fijter, Johan W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Patient-Oriented, Translational Research: Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393825/
https://www.ncbi.nlm.nih.gov/pubmed/35613556
http://dx.doi.org/10.1159/000524851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393825/
https://www.ncbi.nlm.nih.gov/pubmed/35613556
http://dx.doi.org/10.1159/000524851

Ejemplares similares